Here are five things to know:
1. Many consolidation activity is due to biotech firms and product lines growing to compensate for older products whose sales are declining.
2. Abbot plans to purchase St. Jude Medical in a $25 billion transaction.
3. Sanofi put forth an offer to acquire Medivation for nearly $9.3 billion, and AbbVie penned a $5.8 billion deal to acquire Stemcentrx.
4. Many healthcare companies are merging in response to new payment methods and new regulation.
5. Some regulations successfully blocked mergers, including the $150 billion Pfizer and Allergan merger, which was essentially banned due to new inversion regulations.
More healthcare news:
NorthStar Surgical Center turns 15: 3 things to know
30 things for ASC leaders to know for April
Strategic planning for established ASCs: Key thoughts physician-owned facilities
